Fri, January 27, 2023

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $6 on, Jan 27th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-6-on-jan-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Roanna Ruiz of SVB Leerink, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $8 to $6 on, Jan 27th, 2023.

Roanna has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna


  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $4 on, Tuesday, January 24th, 2023